Recombinant Human Tumor Necrosis Factor Receptor (Etanercept) for Treating Ankylosing Spondylitis: A Randomized, Controlled Trial

John C. Davis, Désirée Van Der Heijde, Jurgen Braun, Maxime Dougados, John Cush, Daniel O. Clegg, Alan Kivitz, Roy Fleischmann, Robert Inman, Wayne Tsuji

Research output: Contribution to journalArticlepeer-review

721 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant Human Tumor Necrosis Factor Receptor (Etanercept) for Treating Ankylosing Spondylitis: A Randomized, Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences